Table 1.
Clinical characteristics of the two cohorts of patients admitted in HASU during the two study periods.
| 23rd March to 30th June 2020 (n = 353) | 23rd March to 30th June 2019 (n = 514) | P | |
|---|---|---|---|
| Age, y (median, IQR) | 70.5; 35–98 | 71.0; 24–96 | 0.863 |
| Male, sex (%) | 196 (56.97%) | 250 (49.70%) | 0.134 |
| mRS pre-stroke (median, IQR) | 0; 0–5 | 1; 0–4 | 0.015 |
| NIHSS on arrival (median, IQR) | 7; 0–30 | 4; 0–29 | 0.002 |
| Symptom onset -to-door time, min (median, IQR) | 240; 20–10,080 | 160; 27–23,040 | 0.020 |
| Length of inpatient stay in HASU, days (median, IQR) | 4; 1–60 | 2; 0–20 | <0.001 |
| First healthcare provider contacts used by stroke patients | |||
| GP | 69 (20.05%) | 30 (5.96%) | |
| ED | 172 (50%) | 216 (42.94%) | |
| 999/F.A.S.T. emergency call | 103 (29.95%) | 257 (51.1%) | |
| <0.001 | |||
| Final diagnosis | |||
| Ischaemic stroke | 235 (66.57%) | 283 (55.06%) | |
| Intracranial hemorrhage | 41(11.61%) | 48 (9.34%) | |
| TIA | 18 (5.1%) | 49 (9.53%) | |
| CSVT | 4 (1.13%) | 2 (0.39%) | |
| Stroke mimic | 55 (15.58%) | 132 (25.68%) | |
| <0.001 | |||
mRS, modified Rankin Scale; IQR, interquartile range; HASU, hyper acute stroke unit; GP, general practitioner; ED, emergency department; F.A.S.T., face, arm, speech, time; TIA, transient ischemic attack; CSVT, cerebral sinus venous thrombosis.